BioCentury
ARTICLE | Clinical News

AMG 145: Phase II data

November 12, 2012 8:00 AM UTC

The double-blind, international Phase II RUTHERFORD trial in 168 patients with heFH on a stable dose of statin therapy with or without ezetimibe showed that 350 and 420 mg doses of subcutaneous AMG 14...